ATF4 and colorectal carcinoma: The Eukaryotic initiation factor 2α (eIF2α) and its downstream activating transcription factor 4 (ATF4) overexpression is commonly observed in CRC patients with poor radiotherapy response and is linked to incomplete mitochondrial membrane permeabilization, promoting cell survival [119, 130].